Enzo Biochem Inc. (ENZ) Trading Down 3.2%
Enzo Biochem Inc. (NYSE:ENZ)’s share price fell 3.2% during mid-day trading on Friday . The stock traded as low as $5.65 and last traded at $5.66, with a volume of 81,788 shares changing hands. The stock had previously closed at $5.85.
Separately, Zacks Investment Research upgraded Enzo Biochem from a “sell” rating to a “hold” rating in a research note on Tuesday, May 24th.
The firm has a 50 day moving average of $6.29 and a 200 day moving average of $5.49. The firm has a market cap of $264.17 million and a price-to-earnings ratio of 14.95.
Enzo Biochem (NYSE:ENZ) last issued its earnings results on Wednesday, June 8th. The company reported ($0.04) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.06) by $0.02. The company earned $18.16 million during the quarter, compared to analysts’ expectations of $24.50 million. During the same period in the previous year, the company earned ($0.07) EPS. On average, equities research analysts forecast that Enzo Biochem Inc. will post ($0.23) earnings per share for the current fiscal year.
Enzo Biochem, Inc (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.